Participants 65 124 4
5-year failure-free survival in group III rhabdomyosarcoma:
Participants 352 384 3
osteosarcoma and Ewing's sarcoma
Participants 401 474 5
Rhabdomyosarcoma Study (IRS) IV patients with group III rhabdomyosarcoma,
Participants 588 837 9
We studied 444 group III patients who received induction therapy, had response assessed at week 8 by anatomic imaging, and continued with protocol therapy. Induction chemotherapy was generally followed by radiation therapy (RT) starting after week 9
